Table 1. Clinical Characteristics
Onset of Very Late Stent ThrombosisP Value
All (n=98)Earlier (n=49)Delayed (n=49)
Age, y60.8±12.359.8±12.461.7±12.20.448
Men84 (85.7)40 (81.6)44 (89.8)0.248
Treated hypertension58 (59.2)27 (55.1)31 (63.3)0.411
Treated diabetes mellitus30 (30.6)16 (32.7)14 (28.6)0.661
Current smoking30 (30.6)12 (24.5)18 (36.7)0.188
Total cholesterol, mg/dL152.0 (126.0–183.0)143.5 (123.0–186.3)155.0 (140.0–181.5)0.262
HDL cholesterol, mg/dL41.7 (35.0–48.0)44.0 (36.8–51.1)40.0 (34.0–47.4)0.128
LDL cholesterol, mg/dL86.0 (66.4–107.5)79.5 (60.8–121.3)87.5 (72.3–106.8)0.249
Left ventricular ejection fraction, %51.7±10.353.2±10.750.4±9.80.185
Clinical diagnosis0.225
Non–STEMI48 (49.0)27 (55.1)21 (42.9)
STEMI50 (51.0)22 (44.9)28 (57.1)
Medications
Aspirin83 (84.7)41 (83.7)42 (85.7)0.779
Clopidogrel23 (23.5)15 (30.6)8 (16.3)0.095
Both aspirin and clopidogrel21 (21.4)15 (30.6)6 (12.2)0.027
Statin70 (71.4)35 (71.4)35 (71.4)1.000
  • Data are presented as number (percentage), mean±SD, or median (interquartile range). HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein; STEMI, ST‐segment elevation myocardial infarction.